Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
- PMID: 36746540
- PMCID: PMC9906175
- DOI: 10.1136/bmjopen-2022-068122
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes
Abstract
Introduction: Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes.
Methods and analysis: This scoping review will follow the Arksey and O'Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5).
Ethics and dissemination: As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences.
Keywords: epidemiology; haematology; oncology.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review.BMJ Open. 2022 Jun 2;12(6):e060553. doi: 10.1136/bmjopen-2021-060553. BMJ Open. 2022. PMID: 35654465 Free PMC article.
-
Social science research contributions to antimicrobial resistance: protocol for a scoping review.Syst Rev. 2020 Feb 5;9(1):24. doi: 10.1186/s13643-020-1279-y. Syst Rev. 2020. PMID: 32024549 Free PMC article.
-
Scoping review protocol on the use of social media for health research purposes.BMJ Open. 2021 Feb 11;11(2):e040671. doi: 10.1136/bmjopen-2020-040671. BMJ Open. 2021. PMID: 33574143 Free PMC article.
-
Antimicrobial resistance, antibiotic prescribing practices and antimicrobial stewardship in South Africa: a scoping review.JAC Antimicrob Resist. 2025 Feb 4;7(1):dlaf014. doi: 10.1093/jacamr/dlaf014. eCollection 2025 Feb. JAC Antimicrob Resist. 2025. PMID: 39906361 Free PMC article. Review.
-
Public-targeted interventions addressing antimicrobial resistance and antibiotic use in Sub-Saharan Africa: a scoping review.BMJ Glob Health. 2025 Mar 21;10(3):e017455. doi: 10.1136/bmjgh-2024-017455. BMJ Glob Health. 2025. PMID: 40118465 Free PMC article.
Cited by
-
Transmission of antimicrobial resistance genes from the environment to human gut is more pronounced in colorectal cancer patients than in healthy subjects.Imeta. 2025 Mar 5;4(2):e70008. doi: 10.1002/imt2.70008. eCollection 2025 Apr. Imeta. 2025. PMID: 40236771 Free PMC article.
-
Protein-based nanoparticles for antimicrobial and cancer therapy: implications for public health.RSC Adv. 2025 May 8;15(19):14966-15016. doi: 10.1039/d5ra01427a. eCollection 2025 May 6. RSC Adv. 2025. PMID: 40343307 Free PMC article. Review.
-
Risk factors associated with multidrug-resistant Klebsiella pneumoniae infections: a multicenter observational study in Lebanese hospitals.BMC Public Health. 2024 Oct 25;24(1):2958. doi: 10.1186/s12889-024-20474-0. BMC Public Health. 2024. PMID: 39449026 Free PMC article.
-
Bioactivity and metabolic profiling of crude extracts from endophytic bacteria linked to Solanum mauritianum scope: Discovery of antibacterial and anticancer properties.Heliyon. 2024 Nov 20;11(2):e40525. doi: 10.1016/j.heliyon.2024.e40525. eCollection 2025 Jan 30. Heliyon. 2024. PMID: 39897816 Free PMC article.
-
Genetic determinants of silver nanoparticle resistance and the impact of gamma irradiation on nanoparticle stability.BMC Microbiol. 2025 Jan 13;25(1):18. doi: 10.1186/s12866-024-03682-x. BMC Microbiol. 2025. PMID: 39806286 Free PMC article.
References
-
- Antimicrobial resistance (AMR) and its impact on cancer care. Available: https://www.uicc.org/what-we-do/thematic-areas-work/antimicrobial-resist... [Accessed 2 Jun 2021].
-
- Antimicrobial resistance tackling the burden in the european union. Available: https://www.oecd.org/health/health-systems/AMR-Tackling-the-Burden-in-th... [Accessed 9 Jun 2021].
-
- Cherif DH. Successful cancer treatment relies on effective antibiotics. Available: https://www.reactgroup.org/wp-content/uploads/2020/05/Successful_cancer_... [Accessed 9 Jun 2021].
-
- Hoag JB. Oncology critical care. 2016. 10.5772/61590 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials